Bruno REVERSADE | |
---|---|
Born | 1974 (age 49–50) |
Nationality | French |
Citizenship | French / American |
Alma mater | University of California, Los Angeles [1] |
Children | 4 |
Awards | Society-in-Science, Branco Weiss Fellow (2007), A*STAR Investigator (2008), EMBO Young Investigators (2012), National Research Foundation (2019) |
Scientific career | |
Fields | Mendelian Genetics, Developmental biology, Micropeptides, Hormones |
Institutions | National University of Singapore KAUST |
Doctoral advisor | Edward M. De Robertis |
Other academic advisors | Davor Solter |
Website | www |
Bruno Reversade (born 1978) is an American human geneticist and developmental biologist . He is a Director of the Institute of Molecular and Cellular Biology and the Genome Institute of Singapore at A*STAR (Singapore) and holds several faculty positions at other universities. Reversade is known for identifying mutated genes that cause Mendelian diseases, for his research on the genetics of identical twins and for the characterizations of novel hormones. [2] [3] [4]
Bruno Reversade was born in 1974 into a French-American family. He was raised in Grenoble (France) and Washington, D.C. (US). Bruno Reversade studied at the University Joseph Fourier, Pierre and Marie Curie University and UCLA.
Reversade became interested in developmental biology in 1997 when studying at the University of Western Ontario (Canada) under the tutelage of Greg Kelly. [5] [6]
He earned his master's degree at the Pasteur Institute (Paris, France), where he studied head development in the mouse embryo. [5] [7] He then moved to the United States to work at the HHMI laboratory of Edward M. De Robertis at the University of California, Los Angeles. There he studied the specification of the dorsal-ventral axis during vertebrate development using Xenopus embryos. [8] In 2005, Reversade and De Robertis detailed how multiple extracellular proteins allow embryos that are cut in two to self-regulate consistently. [9] [10] [11]
In 2006, Reversade earned his PhD from the Pierre and Marie Curie University. [12] In 2008, he received the A*STAR investigatorship (Singapore) award and set up his team in 2008 at the Institute of Medical Biology to carry out human embryology and genetic research. [12] [1] [13] In 2015, he became a Director at A*STAR. [14] Also in 2015, he received AAA Fellowship from the Vrije Universiteit Amsterdam and was appointed Professor of Human Genetics at the Centre for Reproductive Medicine at the university's Academic Medical Center. [15] Since 2016, Reversade is a Distinguished Professor of Human Genetics at Koç University (Turkey). [16] In 2023, Reversade became a bioscience Professor at KAUST in the Kingdom of Saudi Arabia.
Reversade's team works on the genetic characterization and clinical description of inherited conditions in humans. [17] [18]
They have identified mutations responsible for progeroid syndromes in humans, [19] [20] [21] NLRP1 inflammasome-related diseases, [22] [23] [24] self-healing cancers [25] [22] and numerous diseases causing birth defects [26] [27] [28]
Reversade's group has identified the following genes to be responsible for novel Mendelian diseases:
Year | Gene | Inheritance | Mendelian disease | Phenotype MIM number |
---|---|---|---|---|
2009 | PYCR1 | Recessive | Cutis laxa, autosomal recessive, type IIB (wrinkly skin syndrome) [19] [29] | 614438 |
2010 | CHSY1 | Recessive | Temtamy preaxial brachydactyly syndrome [30] | 605282 |
2011 | TGFBR1 | Dominant | Multiple Self-healing Squamous Epithelioma (Fergurson-Smith disease) [31] | 132800 |
2012 | IRX5 | Recessive | Hamamy syndrome [32] [33] | 611174 |
2012 | AAGAB | Recessive | Punctate palmoplantar keratoderma, type IA [25] | 148600 |
2014 | KATNB1 | Recessive | Lissencephaly with Microcephaly 6 [34] | 616212 |
2015 | DCPS | Recessive | Al-Raqad syndrome [35] | 616459 |
2015 | ALDH18A1 | Dominant | Dominant Cutis laxa type 3 [20] | 616603 |
2016 | NLRP1 | Dominant | Multiple self-healing palmoplantar carcinoma [22] [36] | 615225 |
2016 | NLRP1 | Recessive | familial keratosis lichenoides chronica (FKLC) [22] [36] | 615225 |
2016 | USP9X | Heterozygous | X-linked syndromic mental retardation 99 [26] | 300968 |
2016 | ELMO2 | Recessive | Primary intraosseous vascular malformation [37] | 606893 |
2017 | ENPP1 | Recessive | Cole disease [38] | 615522 |
2017 | CDK10 | Recessive | Al Kaissi syndrome [39] | 617694 |
2017 | LGI4 | Recessive | Neurogenic Arthrogryposis multiplex congenita with myelin defect [40] | 617468 |
2017 | KIAA1109 | Recessive | Alkuraya-Kucinskas syndrome [41] | 617822 |
2017 | SMCHD1 | Dominant | Bosma arhinia microphthalmia syndrome [42] | 603457 |
2018 | CAMK2A | Recessive | Mental retardation, autosomal recessive 63 [43] [44] | 618095 |
2018 | RSPO2 | Recessive | Tetraamelia syndrome with pulmonary agenesis [28] [45] [46] | 618021 |
2019 | TBX4 | Recessive | PAPPA syndrome [47] | 601719 |
2019 | NLRP1 | Recessive | Congenital juvenile recurrent respiratory papillomatosis (JRRP) [48] | 618803 |
2020 | UGDH | Recessive | Jamuar Syndrome [49] | 603370 |
2020 | MTX2 | Recessive | Mandibuloacral dysplasia progeroid syndrome [21] | 619127 |
2020 | NUAK2 | Recessive | Anencephaly 2 [50] | 619452 |
2021 | C2orf69 | Recessive | Elbracht-Işikay Syndrome [51] | 619423 |
2021 | WLS | Recessive | Zaki Syndrome [52] | 619648 |
2021 | CIROP | Recessive | Visceral heterotaxy-12 (HTX12) [53] [54] | 619702 |
2022 | DPP9 | Recessive | Hatipoğlu syndrome [55] | 608258 |
2022 | FOCAD | Recessive | Severe Liver congenital disease [56] | 619991 |
2022 | TMEM147 | Recessive | Neurodevelopmental disorder with facial dysmorphism & absent language [57] | 620075 |
2023 | TAPT1 | Recessive | Lethal Osteochondrodysplasia [58] | 616897 |
2023 | DRG1 | Recessive | Neurodevelopmental disorder [59] | 603952 |
2023 | RAF1 | Recessive | Progeroid disease [60] | 164760 |
Reversade's investigations in developmental biology have relied on various animal model organisms ( C. elegans , Drosophila , zebrafish, Xenopus and transgenic mice) and covered such embryonic processes as neural induction, [8] limb development, [30] [28] [47] and various human diseases causing birth defects. [42] [50] [52]
In 2005, during his Ph.D. thesis in the laboratory of Edward De Robertis, the scientists published two discoveries, [9] [61] pertaining to the self-regulation of an embryonic morphogenetic field mediated by the extracellular Chordin/BMP/Sizzled pathway. [10] This helped provide a molecular framework for how embryos split in two halves can develop into perfect, albeit smaller, identical twinned embryos. [62]
Reversade also researches the genetics of dizygotic and monozygotic twinning in humans. [63] [5] [4] He has been searching for genes responsible for monozygotic (MZ) twinning from rare population isolates. [64]
In 2021, together with the VU Amsterdam, his group revealed that MZ twins harbor an epigenetic signature in their somatic tissue even decades after their birth. [65] This stable DNA mark could be employed to retrospectively assess if a person is a MZ twin even if his/her co-twin vanished in utero. [66]
Reversade's research has also pioneered the annotation of novel micropeptides. [67]
Joubert syndrome is a rare autosomal recessive genetic disorder that affects the cerebellum, an area of the brain that controls balance and coordination.
The heritability of autism is the proportion of differences in expression of autism that can be explained by genetic variation; if the heritability of a condition is high, then the condition is considered to be primarily genetic. Autism has a strong genetic basis. Although the genetics of autism are complex, autism spectrum disorder (ASD) is explained more by multigene effects than by rare mutations with large effects.
Yunis–Varon syndrome (YVS), also called cleidocranial dysplasia with micrognathia or absent thumbs and distal aphalangia, is an extremely rare autosomal recessive multisystem congenital disorder which affects the skeletal system, ectodermal tissue, heart and respiratory system. It was first described by Emilio Yunis and Humberto Váron from the National University of Colombia.
Transcription factor 4 (TCF-4) also known as immunoglobulin transcription factor 2 (ITF-2) is a protein that in humans is encoded by the TCF4 gene located on chromosome 18q21.2.
T-box transcription factor TBX5, is a protein that in humans is encoded by the TBX5 gene. Abnormalities in the TBX5 gene can result in altered limb development, Holt-Oram syndrome, Tetra-amelia syndrome, and cardiac and skeletal problems.
NLRP1 encodes NACHT, LRR, FIIND, CARD domain and PYD domains-containing protein 1 in humans. NLRP1 was the first protein shown to form an inflammasome. NLRP1 is expressed by a variety of cell types, which are predominantly epithelial or hematopoietic. The expression is also seen within glandular epithelial structures including the lining of the small intestine, stomach, airway epithelia and in hairless or glabrous skin. NLRP1 polymorphisms are associated with skin extra-intestinal manifestations in CD. Its highest expression was detected in human skin, in psoriasis and in vitiligo. Polymorphisms of NLRP1 were found in lupus erythematosus and diabetes type 1. Variants of mouse NLRP1 were found to be activated upon N-terminal cleavage by the protease in anthrax lethal factor.
Dipeptidyl peptidase 9 is an enzyme that in humans is encoded by the DPP9 gene.
Tetra-amelia syndrome, also called autosomal recessive tetraamelia, is an extremely rare autosomal recessive congenital disorder characterized by the absence of all four limbs. Other areas of the body are also affected by malformations, such as the face, skull, reproductive organs, anus, lungs and pelvis. The disorder can be caused by recessive mutations in the WNT3 or RSPO2 genes.
R-spondin 2 also known as roof plate-specific spondin-2 is a secreted protein that in humans that is encoded by the RSPO2 gene.
Coiled-coil and C2 domain-containing protein 2A that in humans is encoded by the CC2D2A gene.
SET binding protein 1 is a protein that in humans is encoded by the SETBP1 gene.
De Barsy syndrome is a rare autosomal recessive genetic disorder. Symptoms include cutis laxa as well as other eye, musculoskeletal, and neurological abnormalities. It is usually progressive, manifesting side effects that can include clouded corneas, cataracts, short stature, dystonia, or progeria.
Piezo-type mechanosensitive ion channel component 2 is a protein that in humans is encoded by the PIEZO2 gene. It has a homotrimeric structure, with three blades curving into a nano-dome, with a diameter of 28 nanometers.
Naomichi Matsumoto is a Japanese physician and medical geneticist who identified several causative genes for human diseases, including Sotos syndrome (2002), Marfan syndrome type II (2004), Ohtahara syndrome (2008), West syndrome (2010), Microphthalmia with limb anomalies (2011), Autosomal-recessive cerebellar ataxias (2011), Hypomyelination with cerebellar atrophy and hypoplasia of the corpus callosum (HCAHC) (2011), Porencephaly (2012), and Coffin–Siris syndrome (2012).
T-box transcription factor Tbx4 is a transcription factor that belongs to T-box gene family that is involved in the regulation of embryonic developmental processes. The transcription factor is encoded by the TBX4 gene located on human chromosome 17. Tbx4 is known mostly for its role in the development of the hindlimb, but it also plays a critical role in the formation of the umbilicus. Tbx4 has been shown to be expressed in the allantois, hindlimb, lung and proctodeum.
Ohad Birk, a physician-scientist, is a professor of human genetics, converging basic scientific research with effective clinical translational applications. Birk's research lab deciphered the molecular basis and mechanism of more than 30 human diseases, including some of the most prevalent severe hereditary diseases in Arabs and in Jews, as well as three syndromes named after Birk. He also implemented his scientific findings in massive carrier testing programs, conducive to 30% reduction in infant mortality rate in the Bedouin community, as well as near-eradication of two of the most common severe hereditary diseases in Sephardic Jews. Birk heads the clinical Genetics Institute at Soroka Medical Center and the Morris Kahn Laboratory of Human Genetics as well as Israel's National Research Center for Orphan / Rare Diseases at Ben Gurion University, and served as director of Israel's National Institute of Biotechnology in the Negev (NIBN) between 2016 and 2017.
Methyl-CpG binding domain protein 5 is a protein that in humans is encoded by the MBD5 gene.
Structural Maintenance of Chromosomes flexible Hinge Domain Containing 1 (SMCHD1) is a protein that in humans is encoded by the SMCHD1 gene. Mutations in SMCHD1 are causative for development of facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS).
Chudley–Mccullough syndrome is a rare genetic disorder which is characterized by bilateral congenital hearing loss associated with brain malformations. It is a type of syndromic deafness.
Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome is a rare genetic disorder which is characterized by multi-systemic symptoms primarily affecting the intellect and post-natal development.